Trial Profile
Symptom relief of gastric acid suppressants in patients with reflux esophagitis - Randomized controlled comparative study of vonoprazan and esomeprazole -
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2017
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 06 Apr 2017 Planned number of patients changed from 50 to 40.
- 24 Feb 2017 New trial record